Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Weight Loss and Supplements Nicotine-metabolites-and-nicotine-dependence

 Sustained release animal repellents
OF THE INVENTION Controlled release formulations in polymeric vehicles have been used for delivery ...


 Substance delivery device
In a first aspect, the pre nt invention provides a substance delivery device comprising a ...


 Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
OF THE PREFERRED EMBODIMENTS The compressed pharmaceutical dosage forms of the present invention ...


 Pharmaceutical compositions containing at least one NSAID having increased bioavailability
OF THE INVENTION The incorporation of Piperine, its metabolites or structural analogues or isomers ...


 Controlled release compositions for macrolide antimicrobial agents
OF THE INVENTION In the context of the present invention a number of terms have been used. In ...


 Novel skin-whitening agent
OF THE INVENTION The active ingredient in the skin-whitening agent of the present invention is the ...


 Microcapsule, treating liquids containing the same, and textile structure having microcapsules adhering thereto
We claim: 1. A textile structure having microcapsules adhered thereto by a binder, said ...


 Water-in-stable L-ascorbic acid derivative and a method for preparation thereof, and a skin-whitening cosmetic composition containing the same
OF THE INVENTION L-ascorbic acid derivative provided by the present invention is 2-(3-Aminopropane ...


 Skin whitener composition containing mercaptodextran
OF THE INVENTION In accordance with the present invention, a skin whitener composition is provided ...


 Composition for external application containing a .beta.-1,6-branched-.beta.-1,3-glucan
OF THE INVENTION Schizophyllum commune Fr. is woody rotting fungi belonging to Agaricales T...


 Nicotine metabolites and nicotine dependence

Details
Inventors: Keenan, Robert M.;
Assignee:
Primary Examiner: Cintins; Marianne M.
Assistant Examiner: Moezie; M.
Attorney, Agent or Firm: Burd, Bartz & Gutenkauf

A therapeutic method is provided to alleviate the tobacco withdrawal syndrome, the symptoms of nicotine withdrawal or the management of human body weight in nicotine-experienced or nicotine-naive individuals, comprising of administering an amount of nicotine metabolites or a pharmaceutically acceptable salts thereof to a human in need of such treatment, in an amount which is effective to reduce or eliminate at least one of the symptoms of the tobacco withdrawal syndrome, nicotine withdrawal or manage human body weight.

DETAILED DESCRIPTION OF THE INVENTION Cotinine ##STR1## Cotinine has the molecular structure shown above; The physiologically active form is the (-)-isomer, so as used herein, the term "cotinine" includes (-)-cotinine, or the racemic form, (+/-)-cotinine.
The free base, depicted above, can be employed in the practice of the invention, as can the pharmaceutically acceptable salts.
These include the amine-acid addition salts of nontoxic organic acids or inorganic acids, such as the tartarate, fumarate ("scotine"), citrate, maleate, malate, hydrobromide, hydrochloride, sulfate, phosphate and the like.
For example, see F.
Vaitekunas, J.
Amer.
Chem.
Soc.
, 79, 149 (1957).
E.
R.
Bowman et al.
, in J.
Pharmacol.
Exp.
Ther.
, 135, 306 (1962) report the preparation of (-)-cotinine free base from (-)-nicotine.
The preparation and purification of (-)-cotinine fumarate is described by N.
L.
Benowitz et al.
, Clin.
Pharmacol.
Ther.
, 34, 604 (1983).
Also, see P.
Jacob III, et al.
, in Pharmacol.
Biochem.
Behav.
, 30, 249 (1988) for an explanation of the metabolic pathways of nicotine and the formation of this metabolic product are discussed.
Nornicotine ##STR2## Nornicotine has the molecular structure shown above; The physiologically active form is the (-)-isomer, so as used herein, the term "nornicotine" includes (-)-nornicotine, or the racemic form, (+/-)-nornicotine.
The free base, depicted above, can be employed in the practice of the invention, as can the pharmaceutically acceptable salts.
These include the amine-acid addition salts of nontoxic organic acids or inorganic acids, such as the tartarate, fumarate, citrate, maleate, malate, hydrobromide, hydrochloride, sulfate, phosphate and the like.
For example, see P.
Jacob III, et al.
, in Pharmacol.
Biochem.
Behav.
, 30, 249 (1988) for an explanation of the metabolic pathways of nicotine and the formation of this metabolic product are discussed.
Norcotinine ##STR3## Norcotinine has the molecular structure shown above; The physiologically active form is the (-)-isomer, so as used herein, the term "norcotinine" includes (-)-norcotinine, or the racemic form, (+/-)-norcotinine



Related patents
  Methods for the inhibition of neointima formation
Compositions and methods are provided for preventing restenosis through local delivery of anti-restenotic agents. In one embodiment of the invention, the localized ...
  Water soluble paclitaxel prodrugs
The present invention seeks to overcome these and other drawbacks inherent in the prior art by providing compositions comprising a chemotherapeutic and antiangiogenic ...
  Method of treating cancer
OF THE INVENTION The present invention relates to a method of inhibiting prenyl-protein transferases which comprises administering to a mammal in need thereof a ...
  Cancer treatment with epothilones
OF THE PREFERRED ASPECTS OF THE INVENTION The present invention deals preferably with the following subject matter as part of the invention: Whenever within this whole ...
  Method and composition for neutralizing house dust mite feces
OF THE PREFERRED EMBODIMENTS In accordance with the present invention, it has been discovered that certain botanical extracts, whether in powder form or in liquid form, ...
  Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
What is claimed is: 1. A method for eliciting an enhanced analgesic and anti-inflammatory response in a mammalian organism in need of such treatment, comprising ...
  Metal-containing compositions, preparations and uses
The invention claimed is: 1. A metal-containing composition consisting essentially of: (i) at least one water soluble metal compound which forms metal ions when ...
  Antioxidant and/or antielastase composition based on lupine oil
What is claimed is: 1. A composition comprising lupine oil or one or more of its fractions for use as an antioxidant and/or antielastase. 2. The composition of claim 1, ...
  Treatment for dry eye syndrome
OF THE PREFERRED EMBODIMENTS The present invention is an improved formulation for the treatment of the underlying inflammatory processes that cause dry eye syndrome. T...
  Repellent aminoalkyldithiocarbamic acids
What is claimed is: 1. A method of repelling rodents or ruminants comprising applying to a rodent or ruminant habitat a repellent amount of a compound of the formula ##EQ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved